Development of [(89)Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer.
开发针对 EGFR 和 c-MET 的双特异性 [(89)Zr]ZrDFO-amivantamab 用于三阴性乳腺癌的 PET 成像
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-020-04978-6
Cavaliere Alessandra, Sun Suxia, Lee Supum, Bodner Jacob, Li Ziqi, Huang Yiyun, Moores Sheri L, Marquez-Nostra Bernadette
